to page content
to site navigation
Explore the Entrepreneurship.org Resource Center to find resources. Designed with entrepreneurs in mind, our resource center allows you to find materials to grow great ideas.
Beth joined Kleiner Perkins Caufield & Byers in May 2005 to work in life sciences. For the past 20 years, she has focused her career on introducing new innovative treatments for AIDS, arthritis, asthma, cancer,
psoriasis, cardiovascular, metabolic, neurological and renal disorders. Seidenberg has introduced 10 innovative products to market and achieved over 40 regulatory approvals, including new indications and formulations, worldwide. These
products have been successfully commercialized and provided benefits to millions of patients with grievous illnesses, and they have generated several billion dollars of revenue. Prior to joining KPCB, Beth was Senior Vice President, Global
Development, and Chief Medical Officer at Amgen, Inc., the world's largest biotechnology company. During Beth's three years there, her responsibilities included all stages of clinical research, regulatory affairs, safety, health
economics/reimbursement and medical affairs. During her tenure, five innovative products were approved for commercial use. Prior to joining Amgen, Beth was a senior executive in research and development at Bristol-Myers Squibb Company and
Merck & Co., Inc. She began her career in basic and clinical research at the National Institutes of Health specializing in immunology and infectious diseases. Beth received her BS from Barnard College magna cum laude, Phi Beta Kappa;
and her medical degree from the University Of Miami School Of Medicine, alpha omega alpha. Her post-graduate training was completed at Johns Hopkins, George Washington School of Medicine and the National Institutes of Health. She is a
member of the Johns Hopkins Bloomberg School of Public Health Advisory Board and Barnard College Science Advisory Board.
Find out who we are highlighting in this week's eMed's 6 entrepreneurs to follow on twitter.
One thing that helps entrepreneurs is networking. So every week @emedcommunity is going to highlight some healthcare and life science entrepreneurs on twitter you should consider following. This is not an endorsement, but an encouragement. Network with your peers!
Taking reasonable steps to protect your trade secrets gives your company a stronger basis for legal action in the event of misuse. Read more to find out what safeguards and remedies are available.
Patents protect inventors and may enrich companies--but the application and registration process may be long and costly. Here are the statutory requirements, plus the basics of an effective patent protection program.
Trademark protection may help a growing company establish, maintain and expand market share. This column, first of a series of three, explains how to meet the criteria for eligible words and symbols when you choose a trademark for your product or company.
Here's how to constitute and file an application to register your trademark. This column, second in a series, also lists the benefits of getting your mark onto either the Principal or the Supplemental Register, or both.
Once your trademark is registered, you'll need an active program to protect its use and ensure compliance. Detailed guidelines, monitoring and taking action against infringers can help.
Balance sheets of many emerging companies show that their intellectual property is their most valuable asset. For that reason, owners and managers must focus their energies and resources on its development and protection.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.
A robust online curriculum for entrepreneurs.
Explore Founders School >
A network of U.S. cities facilitating a weekly entrepreneur education program. Go to 1 Million Cups >
Whether you are starting or growing a company, FastTrac will help you live your dream at each stage.
Get started with FastTrac >